IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 95 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: A prospective open label observational study

Choure Balwant Kisanrao, Gosavi Devesh, Nanotkar Sanjay

Year : 2014| Volume: 46| Issue : 5 | Page no: 493-497

   This article has been cited by
 
1 Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort
Georgios Schoretsanitis, Céline Dubath, Claire Grosu, Marianna Piras, Nermine Laaboub, Setareh Ranjbar, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, Franziska Gamma, Armin Gunten, Kerstin Jessica Plessen, Erich Seifritz, Philippe Conus, Chin B. Eap
Basic & Clinical Pharmacology & Toxicology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
Carla Rognoni, Arianna Bertolani, Claudio Jommi
Clinical Drug Investigation. 2021; 41(4): 303
[Pubmed]  [Google Scholar] [DOI]
3 Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study
Mikel Tous-Espelosin, Sonia Ruiz de Azua, Nagore Iriarte-Yoller, Aitor MartínezAguirre-Betolaza, Pedro M. Sanchez, Pablo Corres, Iñaki Arratibel-Imaz, Agurne Sampedro, Javier Peña, Sara Maldonado-Martín
Psychiatry Research. 2021; 295: 113580
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow